A U.S.-based pharmaceutical manufacturer focused on generic medicines, specialty branded drugs, and biosimilars, supplying products across a wide range of therapeutic areas. The company generates most of its revenue from complex and oral solid-dose generics distributed through wholesalers, pharmacie...
3 members of Congress have disclosed 3 trades in Amneal Pharmaceuticals, Inc. (AMRX), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 2 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2024-09-09 | Rohit Khanna | sell | $1K – $15K |
| 2019-05-29 | Gilbert Cisneros | sell | $1K – $15K |
| 2019-05-24 | Josh Gottheimer | buy | $1K – $15K |